Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 23
Vioxx Plaintiffs Seek Multi-Case Consolidation for First Calif. Trial
Doctors Claim Fraudulent Joinder in Celebrex MDL Suit, Seek Dismissal
Merck Urges Court to Select Only One Case for First Calif. Vioxx Trial
Judge: Plaintiffs' Malpractice Claims Against Physicians Defeat Diversity
Vioxx MDL Judge Orders Deposition of FDA's Dr. David Graham
Plaintiff Says Testimony Wrongfully Excluded, Seeks New Vioxx Trial
Judge Expands Discovery after Vioxx Patient Adds Punitive Damages Claim
Arthritis Drugs - Issue: 22
New York Celebrex/Bextra Counsel Seek Independence, Lower Costs
